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ABSTRACT
This publication was written with the intention of performing an analysis of the
present in-state bioscience initiative and subsequent Mississippi industry incumbents.
Hopefully, this publication will be employed as an informative tool to Mississippi
residents, universities, policy makers and private corporations considering investment in
research and development in the state of Mississippi.
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Foreword
Although many researchers in the industry define biotechnology as the use of a
recombinant DNA technique to synthesize proteins, for the purpose of this publication.
the term “biotechnology” refers to the use of living organisms or their products to modify
the human environment, particularly for the purpose of improving human health.
The use of recombinant DNA in the biotechnology industry did not emerge until
the late 1970’s, and more than two hundred new therapies and vaccines are now on the
market, including cancer treatment products, along with diabetes and HIV treatments. In
addition, more than four hundred drug products and vaccines are currently undergoing
clinical trials. Biotechnology is also the basis of hundreds of medical diagnostic tests that
insure a safe blood supply.
Although agricultural and aquaculture biotechnology directly benefits farmers.
human consumers and the environment are the ultimate beneficiaries of biotech-enabled
efficient agriculture and aquaculture techniques. In addition, environmental biotech
products have increased the efficiency of hazardous materials clean-up through means
such as harnessing pollution-eating microbes. The industrial applications of
biotechnology continue to lead to the development of cleaner, more efficient
manufacturing processes. Most laundry detergents developed in the United States
contain biotech developed enzymes. DNA fingerprinting is a biotechnology process that
has significantly improved the areas of forensics in criminal investigations, as well as
anthropology and wildlife management.
As the biotech industry produces products for human consumption, it is regulated
by the Food and Drug Administration and the Department of Agriculture, along with the

7

Environmental Protection Agency. As of January 2007, there were 1,452 biotech
companies in the United States, 336 of which were publicly traded corporations. The
total value of those publicly traded biotech companies was $360 Billion, as of April 2008.
According to Ernst and Young, in 1992, the U.S. health care publicly traded biotech
companies revenues of $8 billion had risen to $58.8 billion in 2006, spending a collective
total of $27.1 billion on new research and development.
The large amounts of research and development expenditures have led to the
necessity of corporate partnering for biotech companies’ success. In 2007, the collective
biotech industry struck 417 new partnerships with pharmaceutical companies, on top of
473 deals with other biotech companies. In 2004, the U.S. bioscience industry, including
all life-science activities, employed 1.2 million individuals and indirectly generated an
additional 5.8 million industry- related jobs in the United States.
The following graphs illustrate the U.S. Market capitalization and biotech
industry statistics from 1994-2006. Amounts are in billions of U.S.
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In light of the increasing significance of the biotech industry in the U.S. economy,
Mississippi governor Haley Barbour formed Momentum Mississippi in 2005 to promote
the implementation of Blueprint Mississippi, “a strategic plan that identified the number
iil
of recommendations for promoting economic growth," primarily including an increase

in private R&D funding and improved effectiveness of technology transfer and capital

1

Biotechnology Industry Organization. "Biotechnology Industry Facts." 2 Feb. 2009.
<http://bio.org/speeches/ pubs/er/statistics.asp?p=yes>.
9

accessibility to help commercialize innovations.” In addition, Barbour emphasized the
necessity of the Mississippi Technology Alliance(MTA),a non-profit organization with
the mission to “champion innovation and technology-based economic development for
the state of Mississippi.”"
The Mississippi Seed Fund was created by the Mississippi Technology Alliance
in order to provide high-tech, start-up companies with pre-seed financing as well as early
stage risk capital and product development capital in hopes of stimulating and
accelerating the development of technology-based business ventures in the state of
Mississippi.'^ The Seed Fund offers three different types of funding: The Research and
Development Fund, The New Technology Business Fund and the Rural Innovation Fund.
While the Research and Development Fund provides funding for any small
Mississippi company, companies seeking funding through the New Technology Business
Fund must be currently engaged in a development stage prior to production. “This is
further defined as any stage from idea conceptualization up to, and prior to, established
„4

and steady market sales.

suggesting that the firms are in the developmental and

prototype stages of their product’s life cycle. The Rural Innovation Fund provides
assistance to any small company located in a rural area in the state of Mississippi.
Eligible applicants for funding must be involved in the commercialization of
advanced technology. Some examples of industries assisted by the Mississippi Seed
Fund program include: life sciences, information technologies, communications
technologies, aerospace, electronics and related fields, materials, robotics, medical
^ Mississippi Bioscience Initiatives. "Overview and Summary of Recent Initiatives." 2 Feb. 2009. <>.
Mississippi Technology Alliance. "Mississippi Seed Fund". < http://www.technologyalliance.ms/seedfund/>.
Mississippi Technology Alliance. "Mississippi Seed Fund. < http://www.technologyalliance.ms/seedfund/>.
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devices and instalments, telecommunications, agri-sciences and energy services. The
MTA is interested in firms whose products will have a significant competitive advantage
in the marketplace and possess the potential for significant growth, relative to the national
industry sector.
The following table expresses biotech industry subsectors of the state of Mississippi
relative to total U.S. Industry in 2006, including the percent changes from 2001—
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2006':

Bioscience Industry Base, 2006
r,'A

Agricultural Feedstock & Chemicals
Establishments
Employment
Location Quotient
Direct-Effect Employment Multiplier
Total Employment Impact
Average Annual Wage
Drugs & Pharmaceuticals
Establishments
Employment
Location Quotient
Direct-Effect Employment Multiplier
Total Employment Impact
Average Annual Wage
Medical Devices & Equipment
Establishments
I

Employment
Location Quotient
Direct-Effect Employment Multiplier
Total Employment Impact
Average Annual Wage
Research, Testing, & Medical Laboratories
Establishments

I

I

Employment
Location Quotient
Direct-Effect Employment Multiplier
Total Employment Impact
Average Annual^Wage

United States

Mississippi

Industry Subsector
2006

2001-06 Change

2006

2001-06 Change

21

-5.6%
-20.6%

2,183
105,846
n.a.
11.22

3.8%
-6.1%

1,237
1.49
5.46

1,214,709
367,870

6,758
$43,512
18
1,164
0.47
3.36

38.5%
1.0%

3,908

-3.7%
-24.0%

1,782
$31,298
122
843
0.24
1.95

1.9%
4.0%

2,880,242
$86,892

$35,304
82
828
0.25
2.15

2,654
317,149
n.a.
9.92

15,215
422,993
n.a.
4.85

0.3%
-0.9%

1,980,128
$59,441
33.3%
-9.9%

1,645
$42,260

22,857
449,991
n.a.
3.25

32.7%
17.8%

1,440,500
$71,284

Total Private Sector

Establishments
Employment
Average Annual Wage

64,687
889,931
$30,641

8.4%
0.6%

8,575,730
113,463,842
$42,272

10.2%
3.1%

Note: n.a = metric is not applicable.

The following table offers a more specific breakdown of Mississippi bioscience-related
II

performance metrics, including the state’s relative national ranking:
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Additional Bioscience Performance Metrics
Summary of State Performance in Selected Bioscience-related Metrics
Mississippi

United States

Rank

Total(S thousands)

S369.143

$47,760,402

32

Bioscience R&D (S thousands)

$191,450

$29,307,628

33

Bioscience Share of Total R&D

51.9%

Bioscience R&D Per Capita

$66 04

_61.4%
$98 10

Change in Bioscience R&D FY 2002-2006

47.1%

36.9%

Total (S thousands)

$27,914

$21,066,389

Per Capita Funding

$9.56

$69.84

Academic R&D Expondilures, FY 2006

NIH Funding, FY 2007
45

-18.3%

11.2%

Higher Education Degrees In Bioscience Fields, AY 2006

1,316

143.433

34

Employment In Bioscience-related Occupations, 2006

4,390

588,520

35

Bioscience Venture Capital Investments, 2002-2007($ millions)

$11.4

$51,260.9

41

267

121,817

42

Change in Funding, FY 2002-2007

Bioscience and Related Patents, 2002-2007

I

The following graph illustrates the bioscience academic R&D expenditures in Mississippi
in 2006‘":
Bioscience Academic R&D Expenditures in Mississippi, FY 2006
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The following graph illustrates the bioscience-related occupational employment in
Mississippi in 2006":
Bioscience-related Occupational Employment in Mississippi, 2006

/ .
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It should be noted that the label in the above graph, “Agricultural, Food, and Nutrition
Scientists and Technicians,” also includes aquaculture.
The Following Graph illustrates the overall bio-science related venture capital
investments in Mississippi from 2002—2007'':
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Bioscience Venture Capital
Bioscience-related Venture Capital Investments in Mississippi, 2002-2007
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Whereas the graph below illustrates the bioscience-related venture capital investments in
Mississippi by specific industry segments from 2002—2007'';
Bioscience-related Venture Capital Investments in Mississippi by Segment, 2002-2007

Biosensors

I

Biotech-Animal
Biotech-Equipment
Biotech-Human
Biotech-Industrial
Biotech-Other
Biotech-Research
Med/Health-Info Tech

I
I
I
I

f

Med/Health-Products

I $0.6

Med/Health-Services
Medical Diagnostics
Medical Therapeutics

$10.8 f

Pharmaceutical ^
$0

$2

$4

$6

$8

$10

$12

Venture Capital Investments ($ Millions)

15

The following graph depicts the bioscience-related patents by classification group in
Mississippi from 2002—2007'":
Bioscience-related Patents by Classification Group in Mississippi, 2002-2007

r
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The bioscience industry is a vital sector of the state’s economy, providing 889,931
jobs in the private sector with an average annual wage of $30,641. The direct-effect
employment multiplier is indicative of the total household earnings generated by an
initial one dollar fluctuation in household earnings. The direct-effect employment
multiplier allows for the determination of the change in total earnings in the economy of
a particular region by multiplying the initial change in eaimings by the multiplier. In
other words, “the direct-effect employment multiplier shows the total number of Jobs per
initial change in jobs. An estimate of the change in total number ofjobs in a region’s
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economy is calculated by multiplying the initial change in jobs times the direct
employment multiplier.
The direct-effect employment multipliers in the “Bioscience Industry Base, 2006'
table above enable the calculation of the total employment impact in the state of
Mississippi.

●

In the “Agricultural Feedstock and Chemicals” subsector, the direct employment
of 1,237 individuals multiplied by the direct-effect employment multiplier yields
a total employment impact of 6,758, indicative of the generation of 6,758
additional jobs in the state.

●

In the “Drugs and Pharmaceuticals” subsector the direct employment of 1,164
individuals multiplied by the direct-effect employment multiplier equals a total
employment impact of 3,908—the generation of 3,908 additional jobs.

●

In the “Medical Devices and Equipment” subsector, the direct employment of 828
individuals multiplied by the direct-effect employment multiplier generates a total
economic impact of 1,782, or 1,782 additional in-state jobs.

●

Similarly, the direct employment of 122 individuals in the “Research, Testing,
and Medical Laboratories” subsector multiplied by the direct-effect employment
multiplier of 1.95 yields a total economic impact of 1,645, or the generation of
1,645 additional jobs in the state of Mississippi.
The National Institute of Health(NIH)is an agency in the Department of Health

and Human Services whose mission is to employ the sciences in the pursuit of knowledge

^ Bureau of Economic Analysis. "Regional Economic Accounts." 25 May, 2009. < https://www.bea.gov/
regional/rims/rimsii/help.aspx>.
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to improve human health.^ It is the primary biomedical research agency of the federal
government. Organizations within the state will receive funding based on the NIH’s
analysis of the projected generated health-research impact of the apportioned funding.
The presence of pre-established facilities increases the attractiveness of the state to the
NIH regarding the allocation of grants.
Although the state of Mississippi ranked 33*^ in the U.S. for the total “Bioscience
R&D Academic Expenditures,” in 2006 according to the “Summary of State Performance
in Selected Bioscience-related Metrics” above, the state ranked a relatively low 45* in
terms of state receipts of NIH Funding in 2007. Furthermore, as the national trend from
2002 — 2007 is indicative of an increase in overall NIH receipts, the state of Mississippi
saw a net decrease of 18.3% in NIH support. In order for the state to see an increase in
the influx of NIH funding, the timely pursuit of the construction and expansion of
research parks at state universities is imperative, regardless of the present state of the
economy.
Although the amount received from the National Institute of Health was relatively
lower in 2007, the allocated $36 million was responsible for the generation of$69 million
of state economic activity and the generation of 627 new jobs, due to the high directeffect employment multiplier of 1.9, which is typical of bioscience related capacities.^ A
decrease in NIH funding is detrimental to the state’s economy.
Beyond industry and product development, in the agriculture sector alone, the
employment of biotech seeds by farmers in the state theoretically generates a savings of

U.S. Department of Health and Human Services. National Institute of Health. About NIH." 25, May
2007. <http://www.nih.gov/about/NIHovervlew.html>.
Family's USA Global Health Initiative. "In Our Own Backyard." June 2008. 26 April, 2009. <http://
www.famillesusa.org/assets/pdfs/global-health/in-your-own-backyard.pdf>.
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$86,369 million dollars annually based on the total statewide cultivated acreage of com
and cotton—630,000 acres of com and 300,000 acres of cotton.^ Before the advent of
biotech seeds, cotton cultivation typically required the following annual planted-crop
applications:
●

6 applications of weed control herbicide

●

Between 10 and 14 applications of bollworm, budworm and armyworm
insecticides

●

6 applications of boll weevil insecticide

The net result of 19 to 26 annual applications of chemicals on a cotton field required
multiple laborers and labor hours, gallons of chemicals, machine hours and consequential
excessive fuel consumption. The utilization of biotech cotton seeds has enabled farmers
to reduce the number of chemical applications by 15. Factoring in the costs of total
requisite activities and expenses per application, Monsanto representative farmers
approximate the total cost of application per acre is $11.15. Thus, reducing the
applications by 15 through the use of biotech cotton saves Mississippi farmers
approximately $167.25 per acre.^ A similar analysis for the use of biotech seeds for com
cultivation generates a net savings of $57.45 per acre. The environmental benefit as a
result of a large-scale reduction in herbicide and pesticide application should also be
noted.
As the agriculture and aquaculture industries comprise a significant portion of the
state’s economy, Mississippi offers investors interested in the field of biotechnology a

Robinson, Elton. Western Farm Press. Producers to plant lowest cotton acreage in 26 years."
21 M
2009. < http://westernfarmpress.eom/cotton/cotton-production-0402/>.
'
^ Monsanto. "Different Applications for Genetically Modified Crops: Prepared Remarks of Mr. Tho
Dollar." 22, May 2009. < http://www.monsanto.co.uk/news/ukshowli b.phtml?uid=9148>.
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Robinson, Elton. Western Farm Press. "Producers to plant lowest cotton acreage in 26 years." 21, May
2009. < http://westernfarmpress.eom/cotton/cotton-production-0402/>.
^ Monsanto. "Different Applications for Genetically Modified Crops: Prepared Remarks of Mr. Thomas H.
Dollar." 22, May 2009. < http://www.monsanto.co.uk/news/ukshowllb.phtml?uid=9148>.
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unique three prong perspective: agriculture, aquaculture and bio-science pharmaceutical
research. Whether funded through federal or state grants or private entities, the majority
of research takes place on some level through the state universities.

20

I.

Mississippi State University
Mississippi State University is home to the Division of Agriculture, Forestry and

Veterinary Medicine, which is comprised of six major units: the College of Agriculture
and Life Sciences, the College of Forest Resources, the College of Veterinary Medicine,
the Forest and Wildlife Research Center, the Mississippi Agricultural and Forestry
Experiment Station and the MSU Extension Service. Also part of the university’s
Division of Agriculture, Forestry and Veterinary Medicine is the Life Sciences and
Biology Institute (LSBI), which was created in part to “attract financial and intellectual
capital to Mississippi that will improve economic development through the
commercialization of new, enhanced biotechnology products,” as well as to “promote
scientific research and education that meets the needs of society and further enhances the
10

unique strengths of[the] university.
A division of the LSBI, the Department of Plant and Soil Science’s Mississippi
Genome Exploration Laboratory’s(MGEL)mission is in part to “help sustain, protect,
and improve world agriculture and forestry...and [to] discover and characterize economic
and adaptive genes of agricultural organisms,

11

In 2004 a group of MGEL scientists

lead by Daniel G. Peterson received a grant from the Plant Genome Research Program
(PGRP)of the National Science Foundation to participate in a multi-institutional project,
involving the eventual mapping of the loblolly pine genome.

The Accelerating Pine

Genomics(APG)project has been instrumental in generating the physical mapping and

10

Life Sciences and Biotechnology Institute, Mississippi State University. "Mission".
<http.7/www.lsbi.mafes. msstate.edu/>.
Mississippi Genome Exploration Laboratory. "Mission", <http://www.mgel.msstate.edu/mission.htm>.
Mississippi Genome Exploration Laboratory. "Accelerating Pine Genomics".
<http://www.mgel.msstate. edu/apg.htm>.
21

sequencing of the loblolly pine genome, providing critical information for the protection
of the pines, as well as other forest trees whose preservation is essential to raw material
and energy production and conservation. Loblolly pines are an economically important
resource to the state. Through preserving and improving forestry yields, the APG hopes
13

to facilitate the developing realization of conifers as “bioenergy feedstocks.
The U.S. Department of Energy(DOE)recently announced in May that it would
be contracting MGEL’s Daniel G. Peterson to sequence 100 additional loblolly pine BAG
clones. BAG clones, bacterial artificial chromosomes, are a cloning vector developed
14

from artificial DNA constructs.
Aquaculture

As a part of the Division of Agriculture, Forestry and Veterinary Medicine, the
Mississippi State University National Warmwater Aquaculture Genter(NWAG)in
Stoneville, MS was developed to provide solutions to the aquaculture industry through
applied research, in hopes of promoting the growth of the Mississippi economy. As
channel catfish production and its related service industries contribute more than two
billion dollars to the state’s economy each year, aquaculture development is of utmost
importance to the state of Mississippi. In northeast Mississippi, the Delta is in a unique
position to take advantage of the increasing demand for aquaculture products, namely
catfish. The NWAG seeks to solve short term problems as well as conduct research to
develop solutions to problems that threaten the long-term viability of the aquaculture
industry.

Accelerating Pine Genomics. "Long-Term Goals", <http://www.pine.msstate.edu/overview.htm>.
O'Connor, M., M. Peifer, and W. Bender. 1989. Construction of large DNA segments in Escherichia coli.
Science 244:1307-1312.
14
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The NWAC research is divided into several divisions in order to solve both the
short term and long-range problems facing the aquaculture industry. Researchers of the
Nutrition and Feeding division seek to develop lower cost and higher efficiency feeding
methods for catfish, while simultaneously optimizing nutrition. The Production Practices
and Water Quality division seeks to improve production through the development of
better managerial practices. The USDA Agricultural Research Service, Catfish Genetics
Research Unit aims to improve catfish production through developing improved strains
of catfish. The division of Applied Fish Health seeks to develop management strategies
to optimize fish health and minimize the impact of disease on the catfish population,
while the division of Disease Diagnostics seeks to provide a comprehensive disease
diagnostic service, investigating the causes of emerging diseases. The Physiology and
Behavior division studies the physiological side of stress and recovery, spawning
behavior, energy use and swimming performance in different catfish species. The
NWAC also has an entire division dedicated to the research of increasing harvest and
15

catfish grade through the improvement of conventional gear and technologies.

The U.S. Department of Agriculture partnered with Mississippi State University
in 1986, developing the Catfish Genetics Research Unit at the NWAC,to insure the
continued success in production of the catfish industry, realizing the large economic
contribution of the aquaculture industry.

An example of a recent ARS Catfish Genetics

Research Unit development at the NWAC in conjunction with the ARS National

Thad Cochran National Warmwater Aquaculture Center. "NWAC Research".
<http://msstate.edu/dept/tcnwac/ Research.htm>.
US Department of Agriculture. Agricultural Research Service. <
http://www.ars.usda.gov/AboutUs/AboutUs. htm?modecode=64-02-35-00>.
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Coldwater Marine Aquaculture Center located in Orono, Maine, holds the patent title.
Test for Detecting Major Catfish Disease”.
Enteric septicemia, caused by the bacterium Edwardsiella ictaliiri, is one of the
most prevalent diseases affecting channel catfish populations and is consequently
responsible for substantial financial loss for catfish farmers. ARS and MSU researchers
have developed a set of DNA primers along with a DNA probe, specific for the
Edwardsiella ictaliiri bacterium. The new development is a “real time polymerase chain
17

reaction (RT-PCR)test [that] is very specific, accurate, and highly sensitive,

andean

be used as an effective means to detect the disease in live fish populations. In addition to
identifying catfish with active Enteric septicemia infections, the innovative test enables
the identification of surviving fish that may still harbor the Edwardsiella ictaliiri
bacterium, which provides tremendous benefits to disease management and selective
breeding programs.
The early identification of the bacterium and the diagnosis of its resulting
bacterial disease is essential to successful treatment, as the disease progression is usually
quite rapid. Biotechnology companies, as well as companies that manufacture analytical
tools utilizing such biotechnology developments could employ the “Test for Detecting
Major Catfish Disease” to develop diagnostic instruments that enhance the detection of
18

the catfish disease.

The subsequent implementation of this development offers a

tremendous benefit to the U.S. aquaculture industry.
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USDA. Agricultural Research Service. Partnering, <http://www.ars.usda.gov/research/patents/
patents.htm? serialnum=10252357>.
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Mississippi State Technology Commercialization
MSU developed the Office of Technology Commercialization(OTC)to foster an
entrepreneurial environment and identify, assess, protect, market and license the
intellectual properties developed by the faculty and students of the university.'^ The
mission of the OTC is the result of U.S. Public Law 96-517, known as the Bayh-Dole
Act, enacted in 1980, which encouraged universities to “collaborate commercial concerns
,20

to promote the utilization of inventions arising from federal funding,

and requires that

inventions developed by universities under the sponsorship of the federal government be
transferred to the private sector providing for the benefit of the general public. The OTC
is the Mississippi State University equivalent to University of Southern Mississippi’s
Noetic Technologies, Inc.

Office of Technology Commercialization. "Mission Statement".
<http://iptl.msstate.edu/aboutus/whatwedo. php>.
Office of Technology Assessment, United States Congress. "Commercial Biotechnology". <
http://books.ROOgle .com/books?id=nng-Yrr;nxngC&pg=RA2-PA419&lpg=RA2-PA4i Qg^dq-Law i QC517&source=web& ots =QdmsXbxOOu&sig=taEllZ442kvnlPmOFAOU30rsCVE&hl
=en&sa=X&oi=book_result&resnum=10&ct=result#PRA2-PA418,Ml>.
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II.

The University of Southern Mississippi
The University of Southern Mississippi School of Polymers and High

Performance Materials was established in 1970 as the Department of Polymer Science,
while the High Performance Materials distinction was not established until 1999. USM
was the first university in the United States to offer a polymer science degree and still
21

remains a top ten nationally ranked institution of polymer science.
The School of Polymers and High Performance Materials contains two centers,
including the Materials Research Science and Engineering Center, whose objective is to
understand the responses of biological systems,“development of synthetic routes for
macromolecular chain responses, development of environmental stimuli functions
enabling their film formation and analysis, development of techniques for predicting
environmental responses, and understanding formation processes in polymeric films.”
This is of utmost developmental performance because,“materials’ response to internal or
external stimuli formulates the basis of novel materials for the 21^* Century. Polymeric
materials, and in particular polymeric films, have paced the evolution of technologies for
the last 50 years.

.22

In addition, polymers are the basis of groundbreaking developments

of certain drugs, facilitating drug delivery to specific tissues in the body which would
otherwise be impossible.
The National Science Foundation Industry/University Cooperative Research
Center in Coatings (I/U CRC)is another center housed within the School of Polymers
21

School of Polymers and High Performance Materials. "About Us", <http://www.usm.edu/polymer/
research.php>.
22
Materials Research Science and Engineering Center. "About Us".
<http://www.usm.edu/mrsec/index.htm>.
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and High Performance Materials at the University of Southern Mississippi. Established
in 1973, the National Science Foundation Indiistry/University Cooperative Research
Center(NSF/U CRC)program continues to sponsor more than fifty centers in the United
States. The NSF/U CRC established the NSF/U CRC in Coatings in 1990, which
currently provides the largest coatings consortium in the U.S. Funding for the Coatings
Research Center is provided by National Science Foundation member companies and
organizations.
Though not a designated “Research Center,” the Mississippi Polymer Institute
(MPI) is a significant institution within the USM School of Polymers and High
Performance Materials. The MPI was established in 1993 by the state legislature for the
purpose of, “helping the industry solve technical problems, train[ing] employees, and
improv[ing] processes and products so the firms would be prosperous and would grow
„23

and contribute to the economic development of the state,

Three years later, the

institute began receiving additional funding from the federal government’s National
Institute of Standards and Technology Manufacturing Extension Partnership program.
The Mississippi Polymer Institute connects related industries with the academic resources
of the School of Polymers and High Performance Materials by providing consultation
services and expertise in the related sciences, product design, and the polymer materials
manufacturing process to companies and organizations outside of the university.
The International Coatings and Formulations Institute (ICFI) was created in 1998
for the purpose of promoting interaction between USM’s School of Polymers and High
Performance Materials and the coatings industry, with the intent of facilitating industrial.

USM. School of Polymers and High Performance Materials. Mississippi Polymer Institute. "A Resource
to Know Well", <http://www.psrc.usm.edu/mpi/frames.htm>.
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academic, and governmental partnerships for research and development in the coatings
24

and formulations field.'
Marine Science

The University of Southern Mississippi’s Department of Marine Science(DMS)
was developed in 1984 after the state of Mississippi assigned USM the leadership role in
marine sciences. The DMS is located at NASA’s John C. Stennis Space Center(SSC),
nearly seventy-five miles south of USM’s main campus in Hattiesburg. Although the
SSC is the most prominent U.S. rocket testing center, more oceanographers and
hyrdrographers work at the Department of Marine Science facility at the SSC than any
other location worldwide.'^ Hydrography is the science dealing with the measurement
and description of the physical features of bodies of water and their adjacent land
26

masses.

The DMS offers B.S., M.S., and Ph.D. degree programs emphasizing a cross
discipline approach, requiring that all students obtain an understanding and appreciation
of the four major fields of marine science, which are physical oceanography, geological
and biological oceanography, and marine chemistry. The Department of Marine Science
is responsible for a wide range of sub-discipline research including “data assimilation
ocean optics, coastal and marine sedimentology, micropaleontology,

ocean productivity

remote sensing, acoustics, ocean modeling, molecular ecology, and biogeochemistry
24

USM. School of Polymers and High Performance Materials. International Coatings and Formulaf
on
Institute, <http://www.psrc.usm.edu/icfi/>.
*
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The University of Southern Mississippi. Department of Marine Science. "About".
<http://www.usm.edu/ marine /location.php>.
National Oceanic and Atmospheric Association. Office of Coast Survey. "Surveys and Wrecks"
<http://www. nauticalcharts.noaa.gov/hsd/hydrog.htm>.
The University of Southern Mississippi. Department of Marine Science. "Research".
<http://www.usm.edu/ marine /location.php>.
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DSM faculty conduct global research and maintain ongoing projects in geographic
regions such as the Arabian Sea, the Chesapeake Bay, the Great Lakes, Coastal Taiwan,
the Gulf of Mexico, the southern portion of the Mississippi and Pearl Rivers, Rocky
Mountain National Park, the Sargasso Sea, and even the Yukon River basin located in
Anchorage, AK. The University of Southern Mississippi has multiple research centers:
the Center for Trace Analysis(CETA), the Hydrographic Science Research Center
(HSRC), the Undersea Vehicles Technology Center(UVTC)and the Environmental
Radioactivity Laboratory (ERL).
The Center for Trace Analysis(CETA)is responsible for coordinating analytical
services provided by the USM Department of Marine Science. Through the utilization of
the department’s high resolution inductively coupled plasma-mass spectrometer(HRICP-MS), the CETA seeks to provide state of the art research, expertise and analytical
services in trace chemical analysis. Using the HR-ICP-MS, the University of Southern
Mississippi’s CETA provides an unparalleled limit of detection in elemental analysis,
particularly enabling the elemental analysis of waters and solids as well as nutrient and
particulate carbon-Nitrogen Analyses.
The elemental analyses obtained through the use of the HR-ICP-MS provide a
wide range of industry applications. The elemental analyses of waters, rocks, and soils
enable vital information of isotope ratio determinations that are particularly useful to the
Environmental and Earth Science field. The Semiconductor Industry uses the HR-ICPMS data for the determination of reagent purity, while Forensic Sciences utilizes the
analyses for the elemental fingerprinting of crimes scenes. The HR-ICP-MS analyses
enable the Nuclear Industry to trace the location and dispersion of nuclear wastes,

29

promoting their confinement. The health and biological sciences fields and industnes
utilize the elemental analysis of drug purity and the presence of various trace elements m
tissues and fluids in the body. The CETA charges $83.00 per hour for the provision of
service to scholastic and government institutions, while charging the private, commercial
sector a slightly higher rate of $104.00 per hour.
The Undersea Vehicles Technology Center(UVTC)is one of three divisions of
the National Institute for Undersea Science and Technology(NIUST). The NIUST was
established in 2002 in partnership with the National Oceanic and Atmospheric
Administration(NOAA),through the NOAA’s National Undersea Research Program
(NURP), to generate and apply new technologies facilitating the enhancement of
undersea research,'^which encompasses the fields of biotechnology and resulting
engineered technologies in the marine environment. The NIUST consists of two other
divisions, in addition to the UVTC: the Ocean Biotechnology Center and Repository
(OBCR)and the Seabed Technology Research Center(STRC), which are both located at
the University of Mississippi.
As a part of the U.S. Department of Commerce,the NOAA is a federal agency
focused on the condition of the oceans and the atmosphere, playing several distinctive
roles regarding the stewardship of the United State’s living marine and coastal resources.
As a leader in applied science research, the NOAA serves as a principal supplier of
29

environmental information products as well as environmental stewardship services.

The National Undersea Research Program(NURP)consists of a network of six various
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National Oceanic and Atmospheric Administration. NOAA's Undersea Research Program. "National
Institute
for Undersea Science and Technology". < http://www.nurp.noaa.gov/NIUST.htm>.
29
U.S. Department of Commerce. National Oceanic and Atmospheric Administration. "NOAA Careers".
<http:// WWW.careers.noaa.gov/about_noaa.html>.
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regional centers of undersea science and technology enabling the coverage of the widely
diverse U.S. geographic regions. The federal grant supported regional centers

are

primarily located at major universities, including both the University of Mississippi and
the University of Southern Mississippi, which together, are jointly considered an
individual regional center.
The goal of the program at the University of Southern Mississippi’s Undersea
Vehicles Technology Center(UVTC)is the development of viable technologies that
involve interactive communication, systems control, data assimilation and processing,
and artificial intelligence, ultimately appropriate for the operation of both remotely
30

operated underwater vehicles(ROVs)and autonomous underwater vehicles(AUVs).
The technology developed at the UVTC helped enable the development of the Eagle Ray,
the NIUST’s autonomous undersea vehicle. The Eagle Ray is capable of producing highresolution seafloor mapping at depths up to 2200 meters, as well as transporting both wet
and dry payloads, facilitating future instrument and sensor development projects.
The University of Southern Mississippi Technology Commercialization
The University of Southern Mississippi has also developed Noetic Technologies,
Inc., which is a commercial marketing company of the university. Noetic Technologies
provides connections to USM’s technology base and expertise, working closely with
researchers to identify commercially viable opportunities. Noetic Technologies is also
responsible for communicating with industries interested in conducting research through
the university.

National Institute for Undersea Science and Technology. Undersea Vehicles Technology Center".
<http://www.niust.org/index.php/UVTC-lnfo/>.
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Neonatal Developmental Care(NDC)is a specific example of a case study
facilitated by Noetic Technologies, Inc. NDC is a company whose program provides an
essential tool for the parents of premature infants. As NDC possessed the medical
expertise but lacked the business development strategy, the company turned to Noetic for
guidance on negotiating licensing agreements, company formation and branding of the
31

product, as well as the development of a viable marketing plan.

31

Noetic Technologies, Inc. "About Us", <http://noetictechnologies.org/faq.html>.
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III. The University of Mississippi
The National Center of Natural Products Research at the University of Mississippi
hosts a wide variety of research programs. Housed in the Thad Cochran Research
Institute, the NCNPR consists of the following departments and research programs:
Natural Products Discovery, Medicinal Plant Research, Natural Resources and
Environment and the Department of Technology Transfer and Commercialization.
“The Principal objective of the NCNPR’s discovery and development program is
to identify bioactive natural products from plant, marine or microbial sources that may
serve as lead compounds for the development of new pharmaceuticals or
32

agrochemicals,

Scientists from the NCNPR work in collaboration with the scientists

from the University of Mississippi’s School of Pharmacy Department of Pharmacognosy
to collect and locally observe natural product specimens from around the world.
Although some of the specimens are obtained directly from agricultural facilities on the
local Oxford campus, a variety of samples are obtained through collaborations with
federal agencies involving various botanical gardens and other universities. While drug
discovery research emphasizes substances that control various infectious diseases, cancer.
or immune disorders, the discovery and development program also includes agrochemical
projects in collaboration with the USDA Agricultural Research Service that “seek to
identify lead compounds for the development of environmentally benign and
33

toxicologically safe pest management agents.
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The University of Mississippi. National Center for Natural Products Research. "Natural Products
Discovery",
<http://www.olemiss.edu/depts/pharmacy/ncnpr/npd.html>.
33
The University of Mississippi. National Center for Natural Products Research. "Natural Products
Discovery", <http://www.olemiss.edu/depts/pharmacy/ncnpr/npd.html>.
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The U.S. Department of Agriculture(USDA)Agricultural Research Service
(ARS)developed the Natural Products Utilization Research Unit(NPURA)at the
NCNPR at the University of Mississippi in 1996, which remains under the direction of
the Mid-South Area Office of the ARS in Stoneville, MS. The NPURA was chartered
with the primary mission of developing “natural products for use in agriculture in order to
produce more toxicologically and environmentally benign pest management tools and to
improve the nutriceutical value of crops.” In addition, the NPURA engages in
“fundamental research to aid in the development of alternative crops for production of
34

pharmaceuticals and botanical supplements.
Agricultural biotechnology and natural products development encompasses a
growing area of scientific research and development offering a vast economic and
environmental benefit. The basis of the objective of the NPURA is the fact that biotech
developments can be used in agriculture to manage pests “with less risk than synthetic
»35

compounds that are toxicologically and environmentally undesirable.
An example of a recent ARS development at the NCNPR holds the patent title,
“Compounds to Reduce Off-Flavor in Catfish.” After determining that the bacteria
Oscillatoria Perornata, along with the cyanobacteria, blue-green algae, were responsible
for the musty odor in ponds and thus, the consequential “off-flavor” in the catfish which
they produced, ARS researchers discovered a family of natural products that is able to
simultaneously eradicate both pestilences. In addition to the tremendous benefit afforded
to the

private aquaculture industry, the general public also receives an equal benefit from

the implementation of the new development.
34

USDA. Agricultural Research Service. Natural Products Utilization Research Unit.
<http://www.ars.usda.gov/ Main/site_main.htm?modecode=64-08-10-00>.
///;
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Though considered a potential carcinogen, Diuron was typically the only
herbicide available for the treatment of blue-green algae in managed bodies of water,
including rivers and lakes that provided public recreational access. The NCNPR’s newly
developed naturally based and non-carcinogenic technology is more selective towards the
36

undesired blue-green algae and offers a much safer alternative to Diuron.
In addition, current NPURA projects at the NCNOPR include the following:
●

"Fusarhim solani - Extracts of this fungus were shown to be toxic to
weeds such as sicklepod, velvetleaf, and momingglories. Dr. Dayan is
currently investigating the mode of action of a phytotoxin Dr. Rimando
isolated. This work is in collaboration with Dr. Hamed Abbas (Southern
Weed Science Laboratory, USDA ARS,Stoneville, MS).

●

1,8 cineole and cinmethylin - 1,8 cineole is a natural product from which
the herbicide cinmethylin was derived. The mode of action of either of
these compounds on plants remains unknown. The NCNPR is
investigating the possible site(s) of action of these compounds using
physiological and biochemical approaches.

●

Guayule - Current chemical treatments are not wholly effective towards
protection against attack of wood by fungi, termites, and other organisms.
The discovery of the active components of Parthenium argentatum
(Guayule bush) has been undertaken, which are responsible for this plant’s
resin's highly fungicidal and termite protecting characteristics. The
identification of these components will provide us with insights necessary

USDA. Agricultural Research Service. Partnering.
<http://www.ars.usda.gov/research/patents/patents.htm? serialnum=10320651>.
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for development of effective and potent fungicides and termitacides
derived from natural sources.
●

Leiicophyllum friitescens - This desert plant from Texas gave selective
phytotoxicity against monocots in an in vitro screening of several other
plant species. The NCNPR is isolating and testing the active compounds
for herbicidal activity.

●

Castela tcLxana - A promising plant which is highly phytotoxic. Isolated
compounds from this plant were shown to have anti-malarial activity. The
NCNPR is currently isolating and testing the active compounds for
herbicidal activity.

●

Oryza sativa (rice) - A specific rice variety from Taiwan which is highly
allelopathic to bamyardgrass (the biggest weed problem in rice) in field
tests. Identification of the allelochemicals in this variety could lead to
further research on breeding allelopathic rice varieties. This project is in
collaboration with Dr. Bob Dilday (National Rice Germplasm, Evaluation
and Enhancement Center, Stuttgart, AR).

●

Sorghum - Sorgoleone has been known as the active photosynthetic
inhibitor in several species of sorghum. The NCNPR is currently using
computer modeling techniques to design more potent herbicides with
similar structure. There are indications of other phytotoxic constituent(s)
in sorghum, which researchers are attempting to discover. Such a
discovery could lead to breeding studies to give crops major advantages
over weeds. The center is doing research to determine how these
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compounds are produced in sorghum species and how they can be used to
manage weeds. These studies are in collaboration with Dr. Leslie Weston
(Cornell University).
●

Disciila destructivci - The phytotoxins of this plant pathogen that infects
and kills dogwood are being isolated for evaluation for herbicidal activity.

●

Fungicide discovery - All of the compounds discovered by our group and
many of those made available by University of Mississippi personnel will
be examined for activity against crop pathogens.

●

Floiirensia cerniia (tarbush)- This plant is increasing in dominance within
the Chihuahuan Desert of the U.S. It is quite unpalatable to livestock and
contains poisonous compounds. To understand herbivore interactions with
tarbush and in collaboration with the USDA-ARS’Jornada Experimental
Range (JER), the center has undertaken discovering the components
responsible for its unpalatability. This will provide information for the
development of tools necessary for the management of our threatened
rangelands and for the proper utilization of their resources.

●

Drymaria - Several species of Drytnaria are associated with the death of
cattle in the southwestern US. Previous work has associated the toxicity of
Drymaria with compounds known as saponins although, to date, this
remains unproved. Work carried at the USDA-ARS's JER in connection
with plant-animal interactions gave indications of the presence of a
possible toxic component in the volatile fraction of Drymaria pachyphylla.
In co-operation with JER the NCNPR has therefore undertaken to study
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the isolation, identification, and possible bioactivity of this component of
Dnnuiria.
●

Cyperin - This phytotoxic natural product has been isolated from several
plant pathogens. New modes of herbicide action are needed because of
increased weed resistance to herbicides. An unusually rapid rate of
chlorophyll degradation in plants exposed to cyperin has been observed.
The NCNPR is investigating this potentially new mode of action.

●

Artemisia annua (annual wormwood)- Annual wormwood produces
artemisinin, an anti-malarial drug. This compound is also herbicidally
active. Little is known of its mode of action as a pharmaceutical or an
herbicide. The researchers are determining how it works as an herbicide
and are interacting with university scientists to determine how our findings
relate to its effects on the malaria parasite. Dr. Camilo Canel is working
on the identification of genes involved in the biosynthesis of artemisinin
and related compounds, while Dr. Franck Dayan is working with 3-D
modeling to further understand this compound.

●

Hypericum (St. John's wort)- Hypericin is a highly photodynamic
compound produced by several St. John's wort species. The researchers
are interested in understanding how hypericum compartmentalizes this
compound and are investigating the potential use of this compound as a
'contact' pesticide.

●

Peptidomimetic compounds - The NCNPR has found several of these
compounds are highly phytotoxic. The researchers are interested in

38

discovering iheir mode(s) of action and plan on utilizing computer
modeling techniques to maximize their activity. These molecules were
synthesized by Dr. Jordan Zjawiony, of the University of Mississippi with
whom the NUPRA is collaborating on this project.
●

Teipenoid metabolism - Many pesticidal compounds from plants are
terpenoids. A visiting scientist from Spain is investigating the enzymes of
this pathway and how they might be manipulated. This work involves
working with cloned genes and gene products. It will be useful to the
scientists involved in the project below. Transgenic crops with natural
pest resistance - The objective is to improve production of existing natural
compound defenses of crops to pests and to put new natural compound
defenses into crops.

●

Anti-cancer ellagitannins from small fruits - This project is a multiinstitutional collaboration involving cancer prevention using small fruits
between Dr. David Wedge; Dr. Lyndon Larcom,(Clemson University,
Clemson SC); and Dr. Daniel Nixon (Hollings Cancer Center, Medical
University of South Carolina, Charleston SC.)The project will focus on
isolation of natural compounds from strawberries, grapes and raspberries
that have anticancer and antimicrobial activity. This work is fimded by the
USDA Fund for Rural America.

,37
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USDA. Natural Products Utilization Research Unit. "Current Research Projects.'
<http://www.olemiss.edu/ depts/usda/usdaproj.html>.
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Marine Science
Marine biotechnology is a major priority of the NOAA’s National Undersea
Research Program (NURP). Within the mission of the NURP, biotechnology is defined
as “the industrial use of living organisms or biological techniques developed through
,vVS

basic research.

The oceans cover approximately 71% of the surface of the earth and

99% of the biosphere, as organisms are found throughout the entirety of the water
column, consequently representing the greatest extremes in temperature, light and
pressure encountered by living organisms. Adaptation to such harsh environments has
inevitably led to the development of a tremendous degree of bio and genetic diversity,
offering a vast potential of biotechnological applications in the realm of drug discovery,
new resource and industrial processes development, environmental remediation and
increasing the seafood supply and safety.
Located in the University of Mississippi’s National Center for Natural Products
Research (NCNPR), the Ocean Biotechnology Center and Repository(OBCR)consists of
a repository including approximately five thousand marine extracts from the Atlantic,
Pacific, Indian and Southern Oceans. The “overall goal of the OBCR program is to
create a national repository of biochemical^iomolecular products of marine organisms
from US and international waters for use by the biotechnology research sector,”
facilitated through a new initiative focused on biosensor development, in hopes of
developing, “new products from marine ecosystems to enhance human health and well
39

being.

National Institute for Undersea Science and Technology. "Marine Biotechnology: A NURP Priority".
<http://www.nurp.noaa.gov/Biotech.htm>.
39
National Institute for Undersea Science and Technology. Ocean Biotechnology Center and Repository.
"OBCR Goals". < http://www.niust.org/index.php/Ocean-Biotechnology-Center-and-Repository-OBCR/>
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The OBCR facilitates the NOAA research priorities, particularly the development
of new value from the sea in terms of dmg discovery and agrochemicals, eventually for
commercial use. While traditional repositories are merely collections of cells or various
extracts with limited data relative to specific samples, the OBCR is unique in that it
collects a broad range of environmental data accompanying every field sample. Through
the maximization of available data, the OBCR obtains insights into selective pressures
that regulate the expression of significant, observed molecules. In addition, the OBCR
obtains Genomic DNA for every sample, which is archived in a cryofreezer for additional
genetic research. The OBCR's intensive data collecting processes provide an enhanced
data mining opportunity, allowing for insights into interdisciplinary research areas
through statistical Meta-analysis techniques. Environmental data examined within the
context of certain extracts can help identify unique biomarkers that are relevant to marine
toxicology. A biomarker is simply a “substance used as an indicator of a biologic state.
It is a characteristic that is objectively measured and evaluated as an indicator of normal
biologic”‘^^^or pathogenic processes, or pharmacologic responses to therapeutic
intervention. In addition, the OBCR has a renowned Metabolomics program, which is
based on chemical profiles as well as the genomic information of the extracts, obtained
through research at the NCNPR repository.
Fist-sized pieces of each sample, such as algae, sponge, and gorgonian coral, are
collected and identified in the field, before being lyophilized in order to promote their
preservation and help make them more stable. Before being placed on growth plates in
the National Center for Natural Products Research, the extracts are weighed and
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fingerprinted by the HPLC and GCMS processes (High performance liquid
chromatography and Gas Chromatography/Mass Spectrometry).
In addition to the OBCR,the Seabed Technology Research Center is another
division of the NIUST located at the University of Mississippi National Center for
Natural Products Research. Although the STRC is a component of the Mississippi
Mineral Resources Institute (MMRI), the organization receives federal funding from the
NOA A, the U.S. Department of Energy and the Minerals Management Service(MMS).
The MMRI was established in 1972 by the Board of Trustees of the State
Institutions of Higher Learning to promote and coordinate mineral-related research in the
state. The MMRI seeks to provide both the public and private sectors with the necessary
expertise to make responsible decisions regarding national mineral resources and the
consequential environmental welfare.^* Through the support of the MMS,the MMRI
established the Center for Marine Resources and Environmental Technology(CMRET)
in 1987 as one of six national research centers of the former U.S. Bureau of Mines to
facilitate the study of marine minerals and related environmental issues. The CMRET
facilitates the access of both academic and industrial expertise throughout the U.S. and
Canada for the MMS.
The Minerals Management Service is a bureau of the U.S. Department of the
Interior that was established as the federal agency responsible for the management of the
nation’s natural gas, oil and other mineral resources, particularly those on the outer
continental shelf. The MMS is comprised of two major programs, the Minerals Revenue
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The University of Mississippi. The Mississippi Mineral Resource Institute. "Overview". <
http://www.olemiss. edu/depts/mmri/welcome/welcome.html>.
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Management, and the offshore Energy and Minerals Management, which is responsible
42

for the manasement of the mineral resources on the outer U.S. continental shelf.

With the support of the Minerals Management Service, National Oceanographic
and Atmospheric Administration, the Department of Energy’s National Energy
Technology Lab and the Naval Research Lab, the CMRET established the Gas Hydrates
Research Consortium in 2001 to

tudy gas hydrate mounds and active gaseous

hydrocarbon vents in the Gulf of Mexico." In 2006, an observatory in the Gulf of
Mexico was developed through the consortium to facilitate the study of the “dissociation
/ accumulation of gas hydrates and impacts on the adjacent seafloor, water column and
marine biota." As many of the hydrates contain hydrocarbon gases, the research of the
consortium is of particular interest to the energy community in hopes tliat natural gas may
43
be produced and harvested from the hydrates.

Although the observatory’s monitoring

station consists of three types of data collection systems: geochemical, microbial, and
seismo-acoustic, the independently collected data is all connected to the same data
recording and transmission system."^^ In addition, the station’s capabilities are currently
being expanded to enable biological monitoring, permitting the study of “interactions
between life forms and physical/chemical stimuli and of the ways biologic agents
„45

produce or modify geologic materials and processes.
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IV. In-State Pharmaceutical Company Presence
Tlicre is a large pharmaceutical development and manufacturing presence in the
State of Mississippi. Siiiprisingly, a variety of medications tliat have nearly become
common household names were developed and are currently manufactured in
Mississippi.
Wraser Pharmaceuticals is a Madison, Mississippi based pharmaceutical
company, “committed to providing safe, effective, quality branded products at a
reasonable cost for the benefit of patients." Furthermore, Wraser Pharmaceuticals, “is
committed to generating superior returns to investors as well as providing a solid
platform for professional sales representatives to be rewarded at the highest level possible
46

based on exceptional individual performance.

As Wraser’s sales office is located in

Madison, the pharmaceuticals in-state presence inevitably produces an array of regional
sales and marketing jobs in the biotech sector, beyond the research and development and
its necessary funding.
Primarily prescribed by primai'y care practitioners, some of Wraser’s products
include: NuZon Gel, VazoTan Suspension, VazoBid Suspension, Vazol liquid, VazoTab
tablets, Levacet Tablets and Lusonal liquid.
NuZon Gel is a “hydrocortisone Acetate gel with Aloe that provides control in
pediatric eczema, atopic dermatitis, seborrehic dermatitis, contact dermatitis and
47

intertrigo.

in addition to a psoriasis maintenance therapy.

Wraser’s “Vazo’’ line contains dmgs that are used to treat various respiratory
conditions. VazoTan Suspension is cumently the “strongest non-narcotic cough
46
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suppressant on the market,” while VazoBid Suspension is a combination of
antihistamines and decongestants, providing “multi-symptom relief of sneezing, runny
nose, watery itchy eyes, nasal congestion, and post nasal drip.” Vazol Liquid is “a single
agent antihistamine liquid that provides multi-symptom relief of allergic rhinitis, runny
noses, watery, itchy eyes, sneezing and post nasal drip.” VazoTab is another
antihistamine decongestant combination that is “indicated to relieve multi-symptom
allergies and nasal congestion assoeiated with the common cold, sinusitis, allergic rhinitis
and other respiratory conditions.” In addition to the “Vazo” line, Wraser’s Lusonal liquid
is a strawberry flavored “decongestant/expeetorant liquid” that “clears congested sinuses
and thins thick mucous,” that can be administered concomitantly with antibiotics. As a
respiratory illness product geared toward a younger audience, Lusonal liquid has a “great
strawberry flavor without the aftertaste.
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An acne treatment gel combining “the moisturizing effects of a lotion in a gel,”
NuOx Gel is a “unique balanced formula” that is “easy to apply under make-up.”
Resulting in minimal iiTitation that “keeps patients on target,” Wraser’s NuOx Gel is
moisturizing yet effective.

Levacet is a “non-narcotic pain reliever that relieves pain

associated with stress and tension headaches, body and muscle spasms, strains and back
spasms, menstmal and premenstmal symptoms and cramps, and minor arthritis and
,o0

rheumatic pain.

In December of 2008, Wraser publicized an agreement with Ranbaxy
Laboratories, Inc. to promote Ranbaxy topical dermatology products. Princeton, New
Jersey based Ranbaxy Laboratories, Inc.(RLI)is an American subsidiary of India’s
48

Wraser Pharmaceuticals. "Products". 21 Jan. 2009. <http://wraser.com/products.asp?id=60>.
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Ranbaxy Laboraiics Limited (RLL), India's largest pharmaceutical company. While
RLL was established in India 1961, the pharmaceutical company now exports its
products to one hundred twenty-five countries, and is ranked in the top ten generic
51

pharmaceutical companies worldwide.

American based RLI was established entirely

for the sale and distribution of Ranbaxy branded generic prescription products in the
United States.
In order to gain a basic understanding of Ranbaxy USA’s market niche, it is
necessary to first grasp a basic understanding of the concept of generic pharmaceuticals.
A generic dmg is the "bio-equivalent version of a brand name drug.” In order for a
substance to be labeled "bio-equivalent,” as certified by tlie U.S. Food and Drug
Administration, the generic drug "has the same dosage form, safety, strength, route of
administration, quality and performance characteristics and intended use as the branded
version of the dmg.”''~ Although the generic drug may differ slightly from the branded
equivalent in inactive ingredients' composition, the active ingredient composition is
identical, regardless of altered physical appearance due to the presence of fillers and
dyes.
Although most branded drugs obtain a patent following discovery and initial
market introduction, it is rare for a patent to last more than ten years. It is only
reasonable to have some degree of patent rights in order to allow the pharmaceutical
company to generate sales to cover the research and development expenditures. In
addition. Congress can extend the patent of a specific pharmaceutical product to cover the
losses incurred to do extensive government-required testing of the drug. However,
Ranbaxy. "Ranbaxy USA". 21 Jan. 2009. <http://www.ranbaxyusa.eom/genericfaqs.aspx#a>.
Ranbaxy. Ranbaxy USA. "What are Generic Drugs?" 21 Jan. 2009
<http://www.ranbaxyusa.com/genericfaqs. aspx#a>.
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following the expiration of the patent, pharmaceutical companies such as Ranbaxy
53

Laboratories. Inc. have full rights to produce a generic equivalent of the branded drug.
Through working w ith Wraser Pharmaceuticals, Ranbaxy Laboratories hopes to
4*

significantly increase the value of these brands...while providing high-quality
dermatological care to our customer base of physicians and their patients.” Although
none of Ranbaxy's product manufacturing will take place in the Madison, MS Wraser
plant, Ranbaxy feels that Wraser's promotion will increase their dermatological market
share. Through targeting primary care medical practitioners, Wraser hopes to increase
the market level of Ranbaxy's Halog Cream and Ointment, which is a “class two highpotency topical steroid," along with Exelderm Cream and Solution, which is a “broadspectrum imidazole anti-fungal" dmg, and Eurax Cream and Lotion, a “non-steroidal.
.04

prescription anti-puritic.

In an attempt to increase their U.S. dermatological product

market share, Ranbaxy USA recently acquired the drug patents from Bristol-Myers
Squibb in 2007. While Ranbaxy did not initially market the products outside of the
dermatology practice specialty, the India based company hopes that it will gain a
significantly larger portion of the dermatological market share within the primary care
market. As primary care practitioners account for a large percentage of U.S.
dermatological prescriptions, Wraser’s involvement in Ranbaxy’s marketing program is
quite considerable.
More recently, following an intellectual property fomm and technology expo
hosted by the Mississippi Research Consortium and the MTA on November 30*^ 53

Beilis, Mary. Patent, Trademark, and Copyright Primer for Students. Patents in Brief'. 21 Jan 2009.
<http://inventors.about.eom/cs/lessonplans/a/student_primer_2.htm>.
Wraser Pharmaceuticals. "About Wraser Pharmaceuticals". 22 Jan. 2009. <http://www.wraser.com/
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December 31

2008 in Jackson, a partnership was established between Wraser

Pharmaceuticals and the University of Mississippi. Assistant professor at Ole Miss’
Department of Pharmaceutics. Dr. Michael Repka presented his development of
“bioadhesive film platform technology," initially gaining the pharmaceutical company’s
attention at the forum. The following year, in April of 2009, a relationship was
established between Wraser Pharmaceuticals and the university “designed to allow
Wraser to work with the university to identify, develop, register and commercialize new
pharmaceutical products."''''
Also located in Madison, MS. Cypress Pharmaceutical, Inc. is a, “specialty
pharmaceutical company that develops, markets and distributes generic prescription
pharmaceutical products to the leading national pharmaceutical wholesalers, chain drug
stores, distributors, and other retail merchandisers.

.56

Backed by CEO Mtix Draughn.

Cypress Pharmaceuticals, hic. was established in 1983, drawing off of Draughn's vision
and pharmaceutical industry experience. Although Cypress initially opened its doors
producing only one cold symptom treatment product, today the company offers over one
hundred fifty products, including cold medicines, nutritional supplements and dental
health lluorides, along with urinary tract, gastrointestinal, and analgesic drugs.
In 1998. Cypress Pharmaceutical. Inc. started its own branded division. Hawthorn
Pharmaceuticals, Inc. Hawthorn is “a specialty pharmaceutical company focused on the
sales, marketing and development of branded prescription products primarily in
specialty-driven markets including urology, dermatology and pediatrics." Hawthom’s

Wraser Pharmaceuticals. "Press Room". 22 Jan. 2009. <http://wraser.com/press.asp2id=6>.
Reuters. "Company Profile for Cypress Pharmaceutical, Inc." 26 Jan. 2009.
<http://www.reuters.com/article/ pressRelease/idUS170493+18-Jan-2008+BW20080ll8>.
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products ha\c hccii dc\clvipcd aiouiul the Ci>ncept of "practical innovation—improving
existing prodlK[^ and creating new products.*''^
1 law thorn has sex eral product lines, specifically for the areas of dermatology, iron
del iciencics. ncphrolog\. oncologx. pain inanageinent, urology and orally administered
steroids. 1 he dennatoh^gy line contains three types of topical cleansers:
1 1\ lira (lei

is

a topical gel applied for the treatment of xerosis,

/aclir is a facial cleansing lotion containing the active ingredient benzoyl
peroxide that is intended for the topical treatment of mild to moderate
acne.

®

Seuphera is aiuMher 1 lawthorn acne treating topical medication but witli
more extensi\ e use, that can be applied for acne rosacea and seboirheic
dermatitis.

In addition, 1 lawthorn se?lls the "Zaclir kit” containing both a benzoyl peroxide
cleansing loiimi and sodium hyahironate gel. Hawthonis brilliant "kit” marketing allows
consumers to treat facial acne as well as the resulting dry. itchy skin willi one purchase.
Renatahs arc Hawthorn's ''renal vitamin therapy supplements" intended for the
treatment ol wasting syndrome as a result of chronic renal failure, along with uremia and
impaired metabolic functions of the kidney. Hawthorn also produces “Renaltabs with
Iron," allowing a patient suffering from iron deficiency to treat botli problems with one
drug.
C Iranisol is a drug intended for cancer patients for the prevention ol nausea and
vomiting resulting from cmetogenic cancer therapy, including radiation. Veripred 20 is
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Hawthorn Pharmaceuticals, Inc. "Company Focus". 26 Jan. 2009.
<http://www.hawthornrx.com/corporate. html>.
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*‘a pivscnpiion ilm-j piinlii^i mdicaica toi I he a^nlrol of so vcie or incapacitating allergic
coiuliiioiis mti aetaMe !(' ai kHiuaie (rials of eonventional treatment in adult and pediatric
P'>piilalions u ith sea >ona 1 or perennial allergie rhinitis: asthmas; contact and atopic
dernuiiiiis; seniin sKkne'''Si: and di ne h\iKi'sensim it\ reactions.” Zamicet is an oral

''oluiion ludroeodone itartraie and aeeianiinophen pain medication that is used to treat
moderate 1 \ sc\ ere pain. I tira C' is I lau thorn s iindogy drug that is prescribed for die
treatment (d n i itati\ e \ oiding.. indieatetl tor the relief ot local s\iiiptonis. such as
int lamination. li\permotilitx. and pain, which accompany lower urinary tract
inleetions.”

●sS

I ()da\ 1 law thorn Pharmaceuticals. Inc. employs a sales and marketing force of
one hundred twenty indi\ idnals through the ftnited States and has established
relationsliips with all major IPS. pharmaceutical purchasers. The company continues to
pursue product des eU^pment and applications through the research of their in-house drus
development team and currently has thirteen new products in various stages of
development, fueling future growth.
Haw thorn's hranded pharmaceutical products have left plenty of room for
Cypress' generic drug production and market. Cypress outsources all of its
manufacturing and its manufacturing partners have grown trom one to twenty plus from
1993 to 2003. 1 he Madison facility includes 101,000 square teet of warehouse space and
K.OOO square leel of office space. From 1997 to 2003, Cypress won the Cardinal H ealth
Supplier Quality .Award six mit of seven years, joining tlie ranks of other recipients
including Pfi/er, Amgen and Barr Labs. Since its founding, the company’s compou nded
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Hawthorn Pharmaceuticals, Inc. Product Categories". 26 Jan. 2009.
<http://www.hawthornrx.com/corporate. html>.
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annual mowili lal^* lias Ixv'u o\or (M)';

annuallv, charactcvized by sales growth of 85% in

^002 and 2(H) V'
On the other hand. Canton, Mississippi based Allegis Pharmaceuticals is strictly a
pharmaceutical preparations company, signifying that no research takes place at the
Canton location. Allegis is “committed to bringing new products to market and

i'

expanding its sales force each year by partnering with physicians and manufacturers to
.,60

provide optimal product development and patient care.
Some of Allegis' better known products include:
●

QFlex: Administered for the treatment of cold and flu symptoms,QFlex s active
I'

ingredients are acclainin('>phcn and phcnylloloxamine.
●

Allres G: A liquid Tannate Suspension, active ingredients: Carbetapentane Citrate
and Guaifenesin; administered for the treatment of acute respiratory infections.

●

Allres D: A liquid Tannate Suspension; active ingredients: Carbetapentane Citrate
and Pseudophedrine; similar to Allres G, Allres D is a decongestant.

●

Allres Pd: A liquid Tannate Suspension; active ingredients: carbetapentane Citrate
and pseudoephedrine HCl; administered for the treatment of respiratory
infections, similar to Allres D but the HCl salt provides an extended release.

●

NY-Tannic; active ingredients: phenylephrine tannate and chloropeniramine
tannate; as a combination decongestant and anti-histamine drug, NY-Tannic is
administered for the treatment of the symptoms of congestion associated with an
upper respiratory infection.
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Mississippi Business Journal, Mississippi's 40 Fastest Growing Companies; Cypress Pharmaceuticals
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60
Allegis Pharmaceuticals. "About Us." 3 Feb. 2009. <http://www.allegispharma.com/aboutus.html>.

51

●

Seradox LA; aclivc ingredients: Brompheniramine and Phenylephrine:
adnimisiercd lor ^\ nl[MoIn^ o( sinus congestion, pressure, runny nose, sneezing,
and coiigliing as^oa.iicd u iili allergies and upper respiratory infections.

Although its headquarters are located in Deerfield, Illinois, Global healthcare icon
Baxter International, Inc.(NYSE: BAX)has a manufacturing facility in Cleveland,
MS. The company was founded in 1930 as the first commercial manufacturer of outof-hospital- intravenous solutions. In 2006, Baxter employed fourty-eight thousand
employees and boasted sales of $10.4 billion. The innovative bioscience company
offers a diverse product line of blood collection products and blood plasma-derived
pharmaceuticals ($4.4 billion in 2006), along with medication delivery products
including intravenous therapy ($3.9 billion in 2006). Baxter is a world leader in
dialysis products, and grossed $2.1 billion in sales for peritoneal dialysis and
61

hemodialysis products in 2006.
The company opened its second U.S. manufacturing plant in Cleveland, MS in
1950, and cunently employees approximately eight hundred Mississippians. The
Cleveland facility currently produces IV solutions and vaccines.

61

Baxter. About Baxter". 26 Jan. 2009. <http://www.baxter.com/about_baxter/company_profile/sub/
history.html
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V.

University Research Parks
According to the Association of University Research Parks(AURP)there are

currently one hundred and ten university research parks in the United States. The
majority of universities with significant research activities on campus already have a
research park. Southeastern universities that have research parks include Auburn
University, North Carolina State University, the University of Florida, South Florida
University, Clemson University and Virginia Tech. Taking this into consideration, not
only the University of Mississippi, but the state of Mississippi as a whole has fallen
behind other southeastern universities in regard to presence and dominance in the
research sector and the consequential generation of intellectual property and its resulting
revenue.
The University of Mississippi, Mississippi State University and the University of
Southern Mississippi are all in the process of developing research parks, adjacent to the
main campuses of the universities. The initial developments of the research parks are
entirely federally funded, and can be viewed as part of a national economic development
tool. The state only provides funding for the salaries of employees of the research parks.
The University of Southern Mississippi celebrated the ground-breaking of its
“Innovation and Commercialization Park” on May 14*, 2008. USM has received more
than $30 million in initial federal funding and is “poised to transform south Mississippi
into a haven for high-tech, high paying jobs, The aim of the park is to provide
“sustained economic growth by creating new laboratories, offices, and scale up facilities
for joint university and industry projects that turn research into marketable products for
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new and explained business \enlures.

The following image is a schematic of the plans

of the completed park.
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Adjacent to the main campus of Mississippi State, the Thad Cochran Research,
Technology and Economic Development Park strives to be “an ideal environment to high
technology and related businesses.” University centers and institutes along with multiple
businesses are currently located in the park. Presently, the completed Phase I of the park
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The University of Southern Mississippi. Innovation and Commercialization Park. 22 March 2009.
<http://ww\w.usm.edu/research2/icpark.php>.
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i

consists of 272 acres with seven buildings, housing approximately 1500 employees.
Housed in the park. NIST’s High Performance Computing Collabatory is currently
(h

ranked 18 among .-Nmerican universities for supercompiiting power. The Phase II
expansion of the park will include 52 additional adjacent acres.
Like the other major state uni^■ersities of Mississippi, Mississippi State
University’s research park is federally funded, but unlike those of the University of
Southern Mississippi and the University of Mississippi, MSU’s is a joint university and
city-county operation. As the city and county own the development, Mississippi State
has had trouble with joint participation to grow income via the research side. The
following image is a schematic of the plans of the completed ptirk.
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Mississippi State University. The Thad Cochran Research, Technology and Economic Development Park.
General Infornnation". 22 March 2009, <http://www.cochranresearchpark.com/lnformation/>.
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The following images are of the presently completed park (Phase I), north of the main
university campus. I he lirst image is an aerial photo, followed by a labeled schematic:
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Center for
AdvanctHl VehlmUir
Systems

POWE
Institute for
Clean Energ>'
Tochnolog)’
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Mississippi
Tecimolog)' Center
Mulil-teiiani BuMiiig
Research Park ItQs
ScH'lal.Scleiire Research Cenlec

THAD COCHRAN
RESEARCH,
technology,
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Client Logic

Tennessee Valley
Aiitliorily
Service Center

Current Thad Cochran Research, Technology and Economic Development Park tenants
include^’"*:

Center for Advanced Vehicular Systems - www.cavs.msstate,edu
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Mississippi State University, The Thad Cochran Research, Technology an Economic Development Park,
Current Tenants", 22 March 2009, <http;//www,cochranresearchpark,com/information/>.
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Clear Orbit - w u w eloarorhit.com

Cypress Semieondiielor - www.cvpress.com

Harbinger - uu\\ liteeorp.com

High Performance Computing Collaboratory - www.hpc.msstate.edii

11-VI Incorporated - u w w.ii-vi.com

SemiSoiith Laboratories, Inc. - www.semisouth.com

Sitel - WWW .sitel.com

Social Science Research Center - wwvv.ssrc.msstate.edu

Spatial Information Solutions

Tennessee Valley Authority - www.tva.gov

Although the University of Mississippi Research Park is currently in the planning
process, a resource analysis and market feasibility study has already been completed by
George, Henry, George Partners, along with a cost estimate and utilities provision
strategy prepared by Cooke, Doublass, Farr, Lemons, Ltd, in an effort to develop a
master plan for the university park. The mission of the research park is as follows:
●

Fosters intellectual exchange and showcases University-generated
products and research.
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Establishes partnerships with the private sector to encourage collaborative
inno\ ation.
Reinforces the University's academic and research mission.
Contributes to the economic vitality of the state.
The Research Park will serve as a regional hub for research and
technology. As a center of collaboration for the University of Mississippi
and its piiblic/private partners, it will foster an environment of mixed uses
that promotes collaboration through shared research, office, and support
facilities.

In addition, the master plan also highlights the vision of the research park:
●

The research park will be an extension of the main campus of the
university.

●

The research park will be an enabling space of “24-hour” activity,
facilitating interdisciplinary collaboration and the exchange of creative
ideas and knowledge.

●

The research park will serve as an economic engine for the city of Oxford
and the larger region by bringing ideas and research into the market.

●

The research park will be a compact, walkable place that acknowledges
the value of the land and its natural systems.

Furthermore, the long-term success and sustainability of the University of
Mississippi Research Park depends not only on the vision and research goals, but on the
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ability ot the iini\ ersity to create a unique sense of place that will facilitate the ability of
the park to ser\ e as an infomiation exchange hub of social/business interaction. “The
research park will foster cooperation among its various partners and connect the
intellectual pursuits with those of the main campus to create a cohesive learning and
research environment.” The University of Mississippi has developed the following goals
and objectives to insure such a desired cohesive relationship:
To create a physical environment that fosters intellectual exchange and
creativity.
To utilize the park to help the university achieve its academic and research
mission.
To provide facilities that showcase the products and research of the
university.
To establish partnerships with businesses with the intent of encouraging
discovery and collaboration.
To contribute to the economic vitality of the community and state.
To create a sustainable endeavor, generating a legacy for the next
65

generation of leaders.

Regarding the design principles of the University of Mississippi Research Park,
the preservation of the sense of place of the university is of utmost concern. The sight
should serve as an extension of the campus with a mix of uses and amenities that will
make it an attractive locus for both university and business paitners. The plan describes,
65

University of Mississippi Center for Innovation Excellence. Master Plan. "Mission, Vision, Goals and
Objcectives". Feb. 7 2008.
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"The landscape and building character should recall the Ole Miss campus to the extent
possible. The site should be linked as directly as possible to the main campus. Smallscale commercial activity can serve to support the business, technology and research
functions ol the park.
“The aim is to create a place closely associated and linked with the positive
qualities and identity ot the Ole Miss campus, while also creating a unique identity and
sense of place.

drawing Irom the favorable qualities of the campus and town of

Oxford.
The development of the research park should correspond to the site’s preexisting
natural systems and geographical features, including hydrology, landform and the present
ecosystem. Although existing forest should be maintained as much as possible, in an
effort to be mindtul ot the existing natural systems, stream corridors and ponds on the site
should be preserved, protected and integrated into the design of the park. The plan calls
for the incorporation of low maintenance landscape treatments, largely enabled through
the utilization of native plants.
Another important aspect of the design principles focus on the research park site
planning and a building design to maximize both energy efficiency and occupant
comfort. The use of shading is essential to help minimize cooling loads. Green roofs can
drastically reduce solar heat gain and decrease the load on HVAC cooling units. Proper
building orientation has been taken into account when developing the research park
plans, and where possible, the long facade of the buildings will be constructed with an
east-west axis orientation to optimize sun lighting and passive heating and cooling of the
66

University of Mississippi Center for Innovation Excellence. Master Plan. Design Principles" Feb. 7
2008.
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buildings. Additional cxtcnial shading landscaping options have been pursued where
67

such desired east-west a.xis orientation is not feasible.

The university plans to employ the sustainable landscape and greenery options as
a test to see if the nati\ e plant concepts will work on the university main campus as a
whole. If largely successful, the university could drastically reduce landscape
maintenance costs through the incorporation and transition of the more sustainable
alternatives
The University of Mississippi has received twenty-two million dollars in initial
federal grants. Although the university had initially planned on designating twenty
million of this initial sum to develop infrastructure, including grounds, utility provisions,
and roadways, and the remaining two million for an incubator building, the expensive
bridge construction necessary for access to the sight over Highway 6 has resulted in a
postponement and change of initial plans.
In light of the excessive access funding prerequisite, the initial grant could be put
to better use if applied to enable the construction of facilities on campus on the north side
of Highway 6. Immediate construction and consequential use is fiscally favored, as the
leasing of facility space could generate additional capital to partially enable the funding
of the eventual construction of the paik on the south side of Highway 6. Therefore, the
University of Mississippi cuiTently plans to use the initial grant to build two buildings on
the north, existing campus side of Highway 6, totaling an approximate combined fifty to
sixty thousand square feet. One of the buildings will house a wet laboratory while the
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University of Mississippi Center for Innovation Excellence. Master Plan. "Design Principles". Feb. 7
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otlier w ill Infuse a (.lr\ lab. The graphics below depict the projected completed research
park on the sinith side ol Highway 6.
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Above; View toward the Southwest — Note the integration of the preexisting lakes on site.
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Below: Alternative, Birds Eye View" Towards the Southeast
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Above; "Illustrative Master Plan" —Note: The site of the initial two buildings can be seen directly across Highway 6
near the present mecficinal garden facility.

According to the projected economic forecast performed by Tennessee Valley
Authority’.s Dr. Ralph Perhac, following completion, based on 690,000 gross square feet
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of faciliiics, ihc l’m\ crsiiy of Mississippi Research Park will have the following
approximate impact on Lafayette and the surrounding nortli Mississippi counties:
Annual Impact

Direct Employment

Indirect Employment

Total

Retail Spending

S40.S1 1.140

$17,419,050

$58,230,196

Sales Taxes

S2.S56.7S0

Sl.219,334

$4,076,113

Residential
Property Taxes

S1.S4.T049

N/A

$1,843,049

Immediately follow ing state funding and tuition receipts, research is presently the
third largest source of university revenue. In preexisting university research parks,
companies typically lease space in buildings from the universities. However, in some
circumstanecs, companies lease the space from the university and build their own
buildings, owning the facility for the life of the building. The Association of University
Research Parks(AURP)discourages universities to use tlieir own funding to tailor
facilities according to the companies requests. Rather, it is advised that companies lease
the buildings from the universities with customization options and provisions built into
the contract.
Purdue University had trouble in this ai*ea several years ago when a research park
facility-leasing company was acquired by a larger company after Purdue had custom
tailored the space for the specific company. Consequently, a significant sum of
university money was wasted because the space had been company-specific tailored and
was no longer needed following the leasing company’s acquisition.
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VI.

Conclusions and Suhsequcnl Recommendations
Overall, the slate aiul iim\eisities need lo make a grcaier olTort to leverage what

they do well. I he ma|oi ii\ vM neeessarv iesouree> is alreadv present or are in the
development process. A svncigisiie relationship between different programs, whether in
single or eross-nniv ersit \ departments, is essential for maximum eapitalization. It is
ncecssarv that univeistties tocii S I m hvnh hori/ontal and \ertieal cooperation.
acknowledging the aiiraetum o! investing ciunpanies as the ultimate goal. The easier
accessible the brain iriisi and intellectual capital and facilities become, the more desirable
the situations for etmipanies' investments become.
This can be done on a v arietv ol lev els, whether capitalizing on working
collaboratively w ith another single department or school on campus, or working jointly
with another in-state universitv. b'or instance, the faculty of two separate universities can
each submit joint research proposals. .\ current example of a level ofjoint university
research is the University of Mississippi and Mississippi State University working
collaboratively with the USDA.
In addition, a company could work collaboratively with private labs and a
university. For instance, a company could write a grant and work jointly with a lab like
the private Elsohly, Labs in Oxford, MS and the University of Mississippi, capitalizing
on various levels and areas of expertise. Elsohly, Labs is an analytical laboratory that
was started by Dr. Elsohly, a former University of Mississippi Chemistry professor.
Although Elsohly, Labs is a strictly for-profit operation, it serves as an example of how a
university spin-off can generate revenue which ultimately contributes to the state’s
economy.
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On a single university cross-departmental level, a collaborative effort between the
School of Business and the pharmacy department would be mutually beneficial. It would
be extremely helpful for students pursuing degrees in the sciences to learn about the
finances and accounting procedures and regulations governing and consequentially
determining the direction and nature of their work in a given science-related career field.
On the other hand, it would be tremendously helpful for business students to have the
opportunity to learn about technology based innovation and research and development.
Although most current business students are largely unaware, many of their careers could
involve some degree of working for a bio-science company, since there are multiple
opportunities that seem to go unfilled.
Though separated in the value chain from the actual in-lab research and drug
development, it would be beneficial for students and future business workforce
incumbents to understand the major players in the overall process of the industry, have
some since of perception of how long it takes to get a product from the in-lab discovery
stage to market, and to have a grasp of the Food and

Drug Administration regulatory

environment. Individuals should not work with a nan*ow

field of vision, and it is vital to

have some sense of understanding and knowledge of the process.
Although The University of Mississippi’s former three-year MBA program in
pharmaceutical sales provided students with a knowledge
a greater knowledge of the process and overall value

of the pharmaceutical industry

chain, emphasizing in-lab research

of a product to its appeai’ance on pharmacy or supermarket shelves is
Nevertheless, the university’s provision of such a program was

necessary.

a step in the right

direction. However, since the university’s MBA program switched to the

one-year
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(Juration requisite tor completion, the pharmaceutical sales aspect has been completely
eliminated trom the curriculum.
Multiple departments can each contribute to the movement of a product to market.
The Business School can serve as an essential tool, educating students, facilitating fund
acquisition and the subsequent efficient movement of laboratory scientists’ and inventors
products to market.
Reporting directly to the Business School, the Small Business Development
Center(SMDC)on the University of Mississippi campus exists for this very purpose.
The SMDC works with universities all over the country, and the National Center for
Natural Products research is working with them presently. Their expertise is necessary
for the development of successful business plans providing maximum capitalization,
utilizing the intellectual property of University of Mississippi lab scientists at the
National Center for Natural Products Research.
Although I decided to add a chemistry minor to my business degree to obtain the
necessary prerequisite courses necessary for medical school admission, how many
business students understand the properties of a carbonyl, double bond or an aromatic
ring? An understanding of the fundamentals is incredibly useful for the overall
involvement in the industry, whichever end of the spectmm that may be—in-lab
discovery, or marketing strategy and R&D funding. Should I decide not to pinsue
medical school and rather, utilize my business degree, my understanding of the process
and mechanics of the bio-science industry will be extremely useful because of the
inevitable correlation of science and business.
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